Quarterly report [Sections 13 or 15(d)]

Summary of Stock Options Activity (Details)

v3.25.3
Summary of Stock Options Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance 603  
Weighted Average Exercise Price, Beginning Balance $ 4,902.19  
Weighted Average Grant Date Fair Value, Beginning Balance $ 4,595.20  
Weighted Average Remaining Contractual Term (Years) 9 years 1 month 9 days 7 years 11 months 23 days
Aggregate Intrinsic Value, Beginning Balance  
Number of Shares, Granted 2,250  
Weighted Average Exercise Price, Granted $ 18.32  
Weighted Average Grant Date Fair Value, Granted $ 18.32  
Weighted Average Remaining Contractual Term (Years), Granted 9 years 6 months 18 days  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Grant Date Fair Value, Exercised  
Number of Shares, Forfeited (34)  
Weighted Average Exercise Price, Forfeited $ 2,430.00  
Weighted Average Grant Date Fair Value, Forfeited $ 2,310.00  
Weighted Average Remaining Contractual Term (Years), Forfeited 7 years 11 months 8 days  
Number of Shares, Canceled/Expired (78)  
Weighted Average Exercise Price, Canceled/Expired $ 4,980.00  
Weighted Average Grant Date Fair Value, Canceled/Expired $ 4,710.00  
Weighted Average Remaining Contractual Term (Years), Canceled/Expired 7 years 8 months 8 days  
Number of Shares, Ending Balance 2,741 603
Weighted Average Exercise Price, Ending Balance $ 921.63 $ 4,902.19
Weighted Average Grant Date Fair Value, Ending Balance $ 863.26 $ 4,595.20
Aggregate Intrinsic Value, Ending Balance
Number of Shares, Exercisable 2,741  
Weighted Average Exercise Price, Exercisable $ 921.63  
Weighted Average Grant Date Fair Value, Exercisable $ 863.26  
Weighted Average Remaining Contractual Term (Years), Exercisable 9 years 1 month 9 days  
Aggregate Intrinsic Value, Exercisable